Who owns Impax Laboratories?

Key details on Impax Laboratories (Ticker: IPXL)

Who owns Impax Laboratories?

Is IPXL a good stock to own? Find out who bought Impax Laboratories, who sold Impax Laboratories (IPXL) stock, and who holds a large position in Impax Laboratories.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 6.66M $234.64M Sept. 30, 2015
BlackRock Fund Advisors 5.60M $197.24M Sept. 30, 2015
Vanguard 5.18M $221.46M Dec. 31, 2015
ARAVT GLOBAL 3.44M $121.30M Sept. 30, 2015
Visium Asset Management 3.40M $52.50M March 31, 2013
Franklin Resources 3.34M $117.53M Sept. 30, 2015
Pennant Capital Management 3.20M $147.13M June 30, 2015
Inves 3.14M $110.56M Sept. 30, 2015
Wells Fargo & Company 2.71M $55.10M June 30, 2012
CITADEL ADVISORS 2.47M $38.20M March 31, 2013
RS INVESTMENT MANAGEMENT 2.35M $59.09M Dec. 31, 2013
Wellington Management Company 2.23M $45.64M Dec. 31, 2012
STATE STREET CORPORATION 1.94M $68.46M Sept. 30, 2015
FMR 1.87M $87.85M March 31, 2015
Jennison Associates 1.72M $51.63M June 30, 2014
TCW 1.66M $42.96M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 1.65M $58.06M Sept. 30, 2015
Ameriprise Financial 1.63M $43.13M March 31, 2014
ALLIANCEBERNSTEIN 1.61M $41.79M Sept. 30, 2012

Who sold Impax Laboratories?

Fund Name Date Sold Number of Shares Sold Share Valuation
FRIESS ASSOCIATES March 31, 2011 2.19M $55.70M